Evaluation of Drugs and Strategies for Treating Coronary Artery Ectasia: Update and Future Perspective
Jundishapur Journal of Chronic Disease Care · 2022
DOI: 10.5812/jjcdc-123301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jundishapur Journal of Chronic Disease Care, 2022. Verfasst von Mohammad Javad Taghizadeh und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Context
Although the mechanisms involved in the pathogenesis of coronary artery ectasia (CAE) and its treatment methods are not known for certainty, increased inflammatory and coagulation responses can be responsible for the formation of ectasia due to vascular disorders. Evidence Acquisition: The content used in this paper was obtained from English language articles (2005 - 2020) retrieved from the PubMed database and Google scholar search engine using “coronary artery ectasia”, “treatment”, “drug”, and “aneurysm” keywords.
Results
The proven effect of inflammation and coagulation in CAE has posed a significant challenge for disease management. Therefore, anti-inflammatory and anticoagulation drugs can be treatment options for these patients. Increased inflammatory responses and some coagulation factors in CAE patients is undeniable. The study of these two systems in CAE patients and the evaluation of drugs affecting these mechanisms to achieve a definitive conclusion requires further and more extensive studies.
Conclusions
We evaluated the hypothesis that anti-inflammatory and anticoagulation drugs with improved vascular endothelial function may accelerate the healing process of CAE patients; thus, they may be treatment options. Finally, it can be said that identifying molecular pathways related to drugs can improve their effectiveness in treating patients and increasing their survival. In addition, identifying upstream and downstream pathways can help diagnose the disease pathogenesis in addition to treating patients.
Zitieren
APA
Taghizadeh, M. J., Khodadadi, S., & Zamanifard, S. (2022). Evaluation of Drugs and Strategies for Treating Coronary Artery Ectasia: Update and Future Perspective. Jundishapur Journal of Chronic Disease Care. https://doi.org/10.5812/jjcdc-123301
Vancouver
Taghizadeh MJ, Khodadadi S, Zamanifard S. Evaluation of Drugs and Strategies for Treating Coronary Artery Ectasia: Update and Future Perspective. Jundishapur Journal of Chronic Disease Care. 2022. doi:10.5812/jjcdc-123301
BibTeX
@article{Taghizadeh2022,
author = {Taghizadeh, Mohammad Javad and Khodadadi, Shima and Zamanifard, Somayeh},
title = {Evaluation of Drugs and Strategies for Treating Coronary Artery Ectasia: Update and Future Perspective},
journal = {Jundishapur Journal of Chronic Disease Care},
year = {2022},
doi = {10.5812/jjcdc-123301}
}
EUVIMED